Skip to content
Great news for kids: OSSIOfiber® Metal-Free Compression Screws and Trimmable Fixation Nails are now FDA cleared for various bone fractures in children (ages 2-12) and adolescents (ages 12-21). Read More

ASPS Webinar

← All Posts

Earn CECH credits by watching this recent webinar, hosted with American Society of Podiatric Surgeons and presenter Bob Baravarian, DPM, FACFAS. 

NOW ON-DEMAND

WEBINAR: The Science and Clinical Experience with Strong and Bio-Integrative Implant Fixation
Bob-Inner-2

Speaker: Bob Baravarian, DPM, FACFAS

 

Hear Dr. Baravarian present on:

  • Science behind the strong and bio-integrative OSSIOfiber Technology
  • First-in-human clinical study results 
  • Potential of OSSIOfiber Technology as an alternative to metal hardware for multitude of applications across orthopedics 
  • Surgical techniques for commercially available products (OSSIOfiber Hammertoe Fixation System and OSSIOfiber Trimmable Fixation Nails)
  • Case reviews utilizing the OSSIOfiber Trimmable Fixation Nails for a Lisfranc, 1st MPJ fusion, Tailors Bunionectomy and Calcaneal Osteotomy

Log in to the ASPS website to access the webinar and earn CECH credit! 

Asps Webinar

Please note to receive CECH credit, active ASPS membership or additional access may be required.

Bob Baravarian, DPM

Bob Baravarian, DPM

Bob Baravarian, DPM, is a member of the UCLA Medical Group, Chief of Podiatric Foot and Ankle Surgery at Santa Monica UCLA Medical Center and Orthopedic Hospital, and Assistant Clinical Professor at the UCLA School of Medicine. Dr. Baravarian received the foot and reconstructive rearfoot and ankle certifications as a Fellow of ACFAS. He also serves as Editor Emeritus of Foot and Ankle Specialist.

Related Posts

Case Study: A Clinical Approach to Treating Hammertoe Deformities with a Bio-Integrative Fixation Implant

Hammertoe deformities are one of the most common foot deformities, estimated to affect one third of the population.1 Intramedullary implants have gained popularity over the past decade, with the advantage of avoiding an external, percutanous K-wire during the rehabilitation phase. There are many on the market, manufactured from a variety of implant materials including conventionalContinue reading “Case Study: A Clinical Approach to Treating Hammertoe Deformities with a Bio-Integrative Fixation Implant”

Ossio Faculty July 7, 2021

First-in-Human, Prospective, Multicenter Clinical Study

OSSIO is thrilled to announce the publication of our prospective, multicenter, first-in-human clinical trial in Foot & Ankle Orthopaedics.  Prospective, Multicenter, Clinical and Radiographic Evaluation of a Biointegrative, Fiber-Reinforced Implant for Proximal Interphalangeal Joint ArthrodesisLuke D. Cicchinelli, DPM, Jurij Štalc, MD, Martinus Richter, MD, PhD, Stuart Miller, MD Twenty-five patients underwent PIPJ fusions with OSSIOfiber HammertoeContinue reading “First-in-Human, Prospective, Multicenter Clinical Study”

Co-Principal Investigator’s Overview of First-in-Human Clinical Study

The first-in-human clinical study for OSSIOfiber Intelligent Bone Regeneration Technology was a multicenter, prospective, single-arm study designed to primarily focus on proving the safety and efficacy of the material technology for hammertoe correction arthrodesis.  At 6 months, the study’s results were published in Foot & Ankle Orthopaedic Journal. Hear co-principal investigator, Luke Cicchinelli, DPM, speakContinue reading “Co-Principal Investigator’s Overview of First-in-Human Clinical Study”

Luke Cicchinelli, DPM November 3, 2020

Interested in OSSIOfiber®?

Complete the form and an OSSIOfiber® Advisor will get in touch.

Customer Service

For product inquiries or purchasing questions contact 833-781-7373 or email info@ossio.io

Address

Commercial Headquarters
OSSIO Inc
300 Tradecenter Drive, Suite 3690
Woburn, MA, 01801

Science & Manufacturing Center

OSSIO Ltd.
8 HaTochen Street
Cesarea, Israel 3079861

OSSIOfiber® has been used by over 1500 surgeons across the US

Footnotes

1. Data on file at OSSIO 2. Clinical study data on file at OSSIO 3. Kaiser, P.B., Watkins, I., Riedel, M. D., Cronin, P., Briceno, J., Kron, J. Y. (2019). Implant Removal Matrix for the Foot and Ankle Orthopaedic Surgeon. Foot & Ankle Specialist, 12(1), 79-97. https://doi.org/10.1177/1938640018791015 4. Pre-clinical animal studies (in-bone implantation of OSSIOfiber® and PLDLA control in rabbit femurs). Data on File at OSSIO. 5.Haddad, S. F., Helm, M. M., Meath, B., Adams, C., Packianathan, N., & Uhl, R. (2019). Exploring the Incidence, Implications, and Relevance of Metal Allergy to Orthopaedic Surgeons. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 3(4), e023. https://doi.org/10.5435/JAAOSGlobal-D-19-00023